VANGUARD GROUP INC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 146 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,532,762
-13.8%
1,484,268
+7.4%
0.00%
Q2 2023$13,382,764
-8.1%
1,382,517
+4.1%
0.00%
Q1 2023$14,556,086
+145.1%
1,328,110
-3.4%
0.00%
Q4 2022$5,937,939
-34.6%
1,374,523
+13.8%
0.00%
Q3 2022$9,081,000
-22.7%
1,207,609
+3.3%
0.00%
Q2 2022$11,749,000
+79.0%
1,168,957
+120.5%
0.00%
Q1 2022$6,562,000
-31.6%
530,059
+26.3%
0.00%
Q4 2021$9,599,000
+497.3%
419,705
+478.0%
0.00%
Q3 2021$1,607,000
+71.0%
72,611
+0.1%
0.00%
Q2 2021$940,000
-21.7%
72,536
-21.5%
0.00%
Q1 2021$1,200,000
-8.8%
92,426
-2.9%
0.00%
Q4 2020$1,316,000
+11.7%
95,154
+19.0%
0.00%
Q3 2020$1,178,000
+26.5%
79,928
+39.5%
0.00%
Q2 2020$931,000
-34.0%
57,302
-41.0%
0.00%
Q1 2020$1,410,000
+45.2%
97,146
+102.6%
0.00%
Q4 2019$971,000
+526.5%
47,949
+65.2%
0.00%
Q3 2019$155,000
-18.8%
29,0200.0%0.00%
Q2 2019$191,000
+20.1%
29,020
+18.6%
0.00%
Q1 2019$159,000
+57.4%
24,471
+65.7%
0.00%
Q4 2018$101,000
+3.1%
14,7710.0%0.00%
Q3 2018$98,000
+18.1%
14,7710.0%0.00%
Q2 2018$83,000
+7.8%
14,7710.0%0.00%
Q1 2018$77,000
+14.9%
14,7710.0%0.00%
Q4 2017$67,00014,7710.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders